Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction

[1]  D. Doyle,et al.  Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. , 1989, The New England journal of medicine.

[2]  Y. Koiwaya,et al.  Angiographic features in the infarct-related artery after intracoronary urokinase followed by prolonged anticoagulation. Role of ruptured atheromatous plaque and adherent thrombus in acute myocardial infarction in vivo. , 1988, Circulation.

[3]  P. Théroux,et al.  Aspirin, heparin, or both to treat acute unstable angina. , 1988, The New England journal of medicine.

[4]  A. Moss,et al.  Occurrence, characteristics and prognostic significance of early postacute myocardial infarction angina pectoris. , 1988, The American journal of cardiology.

[5]  A. M. Skene,et al.  TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.

[6]  R. Califf,et al.  Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. , 1988, The American journal of medicine.

[7]  J. Alpert,et al.  Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction. , 1988, American Journal of Cardiology.

[8]  Sol Sherry,et al.  Thrombolytic Therapy: Current Status , 1988 .

[9]  A. Jaffe,et al.  Myocardial infarct extension: occurrence, outcome, and risk factors in the Multicenter Investigation of Limitation of Infarct Size. , 1988, Annals of internal medicine.

[10]  K. Johannessen,et al.  Left ventricular thrombi after short-term high-dose anticoagulants in acute myocardial infarction. , 1987, European heart journal.

[11]  A. Ross,et al.  Reinfarction, recurrent angina, and reocclusion after thrombolytic therapy. , 1987, Circulation.

[12]  Isis Pilot Study Investigation.  Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction , 1987 .

[13]  D. Waters,et al.  Early postinfarction ischemia: clinical, angiographic, and prognostic significance. , 1987, Circulation.

[14]  G. Gensini,et al.  EFFECTIVENESS OF LOW-DOSE HEPARIN IN PREVENTION OF MYOCARDIAL REINFARCTION , 1987, The Lancet.

[15]  S. Arvan,et al.  Prophylactic anticoagulation for left ventricular thrombi after acute myocardial infarction: a prospective randomized trial. , 1987, American heart journal.

[16]  M. Parker,et al.  Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction. , 1987, The American journal of cardiology.

[17]  G. Specchia,et al.  Clinical and angiographic data in early post-infarction angina. , 1986, European heart journal.

[18]  V. Fuster,et al.  Antithrombotic therapy for acute myocardial infarction: mechanisms and prevention of deep venous, left ventricular, and coronary artery thromboembolism. , 1986, Circulation.

[19]  R. Kleiger,et al.  Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. , 1986, The New England journal of medicine.

[20]  P. Guéret,et al.  Effects of full-dose heparin anticoagulation on the development of left ventricular thrombosis in acute transmural myocardial infarction. , 1986, Journal of the American College of Cardiology.

[21]  V. Fuster,et al.  Intracardiac thrombi and systemic embolization. , 1986, Annals of internal medicine.

[22]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[23]  R. W. Brower,et al.  DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTION , 1985, The Lancet.

[24]  S. Domenicucci,et al.  MYOCARDIAL INFARCTION Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction : a two-dimensional echocardiographic study , 2022 .

[25]  M. Simoons,et al.  IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION A Randomised Trial by the Interuniversity Cardiology Institute in The Netherlands , 1985, The Lancet.

[26]  J. Nordrehaug,et al.  Usefulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial infarction. , 1985, The American journal of cardiology.

[27]  R. W. Brower,et al.  Prediction of mortality during the first year after acute myocardial infarction from clinical variables and stress test at hospital discharge. , 1985, The American journal of cardiology.

[28]  J. Ritchie,et al.  The effects of antithrombotic drugs in patients with left ventricular thrombi: assessment with indium-111 platelet imaging and two-dimensional echocardiography. , 1984, Circulation.

[29]  J. Cinca,et al.  Prognostic implications of early spontaneous angina after acute transmural myocardial infarction. , 1983, International journal of cardiology.

[30]  C. Visser,et al.  Left ventricular thrombus following acute myocardial infarction: a prospective serial echocardiographic study of 96 patients. , 1983, European heart journal.

[31]  D. Wilson,et al.  Comparison of Indium-111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. , 1982, The New England journal of medicine.

[32]  A. Telford,et al.  TRIAL OF HEPARIN VERSUS ATENOLOL IN PREVENTION OF MYOCARDIAL INFARCTION IN INTERMEDIATE CORONARY SYNDROME , 1981, The Lancet.

[33]  R. Asinger,et al.  Observations on detecting left ventricular thrombus with two dimensional echocardiography: emphasis on avoidance of false positive diagnoses. , 1981, The American journal of cardiology.

[34]  A. DeMaria,et al.  Left ventricular thrombi identified by cross-sectional echocardiography. , 1979, Annals of internal medicine.

[35]  P R Reid,et al.  Myocardial-infarct extension detected by precordial ST-segment mapping. , 1974, The New England journal of medicine.

[36]  A Drapkin,et al.  Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction. , 1972, JAMA.

[37]  E. Rice-wray.  AN ASSESSMENT OF LONG-TERM ANTICOAGULANT ADMINISTRATION AFTER CARDIAC INFARCTION. SECOND REPORT OF THE WORKING PARTY ON ANTICOAGULANT THERAPY IN CORONARY THROMBOSIS TO THE MEDICAL RESEARCH COUNCIL. , 1964, British medical journal.